Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trial.
29 August 2017 (10:35 - 10:55)
Organised by:
Slides
About the speaker
University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
Access the full session
The Event
ESC Congress 2017
29 August 2017
10:35 CET
You may be interested in
Congress Presentation
1 September 2025
Congress Session
Congress Presentation
Congress Presentation
26 August 2022
